However, for the Asian population, there was no significant association between the IL-10 (-1082 A/G) and hepatocellular carcinoma in heterozygous model (OR:0.97, 95% CI: 0.75–1.25, I2 = 39%, fixed effect model, five studies) (Fig. 3). Here, IL10 is linked to hepatocellular carcinoma.